CHI's 2nd Annual YEAST GENOMICS
	Cambridge Healthtech Institute (CHI) , Miami, Florida January 20-21, 2000
	Saccharomyces cerevisiae was the first eukaryotic genome to be completely sequenced.. In the four years since the sequence was completed, yeast has become even more important as a model organism for functional genomics and drug discovery. The lessons and techniques learned using yeast are paving the way for future studies as the sequencing of the human genome nears completion. This meeting will focus on the latest research into yeast functional genomics and drug discovery, including expression monitoring, protein-protein interactions using the yeast two-hybrid system, and transgenic yeast as a tool for drug screening and exploring human gene function.
	Organized by:	CHI
	Deadline for Abstracts:	December 3, 1999
	Registration:	On-line when brochure is available.
	Email for Requests and Registration:	jlaakso@healthtech.com
	Posted by: Jennifer Laakso   Host: wks137.healthtech.com date: June 23, 1999 19:40:38 Generated by meetings and positions 2.0 by Kai Garlipp Logo and Logo Images by Art for BioMed / Syrinx GmbH - Frankfurt / Germany. 4.1 (c) 1995-99 HUM-MOLGEN. All rights reserved. Liability and Copyright.